Navigation Links
DEA Approves MMJ International Holdings THC Shipment for Multiple Sclerosis, Huntington's Disease Drug Development
Date:11/22/2019

MMJ International Holdings, the premier medical cannabis research company, announced that it has received DEA approval to ship THC and CBD from Canada. MMJ International Holdings is developing oral drug products from natural whole plant extract derivatives from the marijuana plant containing THC and CBD. MMJ will be utilizing its new products for an FDA approved treatment of multiple sclerosis (MS) and Huntington's disease (HD). "As MMJ International Holdings continues to advance to its clinical trials, a specialty pharmaceutical solutions company will be supporting MMJ with the FDA, DEA required development API and specialized liquid encapsulation solutions," said Elio Mariani, PhD, EVP of Research & Development. "Patients will benefit from cGMP-quality therapies in an accessible and efficient format.”

Most recently the FDA awarded MMJ International Holdings ?Orphan Drug Designation? for its THC and CBD proprietary drug formulation which will be used for the treatment of Huntington's Disease. MMJ is confident that their pharmaceutical drugs will bring much needed relief to patients suffering from the debilitating effects of Multiple Sclerosis and Huntington's Disease. "We firmly believe that our MMJ natural whole plant derived molecules with a unique combination of pharmacological properties will be FDA approved as a safe and effective prescription drug that can be of great benefit in treating patients with MS and HD diseases," said Duane Boise, CEO of MMJ International Holdings."We are pleased with the DEA 's cooperation and support to facilitate our company mission to service the unmet needs of patients suffering from these chronic diseases.” Tim Moynahan the company chairman stated that "Patients in the MMJ International holdings clinical trials will receiv e gelatin capsules containing THC and CBD daily.”

MMJ International Holdings has several academic institutions preparing to study cannabis in Multiple Sclerosis and Huntington's disease. "MMJ clinical trials will provide the necessary data to prove that cannabis can treat essential tremors, a neurological disorder that causes involuntary shaking.” Tim Moynahan further stated that, "Ultimately, there's so much interest in THC and CBD as a treatment modality, so MMJ will be providing the clinical research data necessary to prove patient dosing, safety, and efficacy.” MMJ International Holdings continues its process of scientific drug development and discovery by FDA protocol development processes, intellectual property portfolio and DEA regulatory manufacturing guidelines.

About MMJ International Holdings:

MMJ International Holdings has established a leading position in the development of plant-derived cannabinoid therapeutics through its proven drug discovery and development processes, intellectual property portfolio and regulatory and manufacturing expertise. MMJ is successfully developing several prescription medications derived from the cannabis plant for the treatment of spasticity and chorea due to multiple sclerosis and Huntington’s disease.

The company has a pipeline of additional clinical stage cannabinoid and other natural botanical product candidates for both orphan and non-orphan indications with a specific focus on neurological conditions.

For more information visit: http://www.mmjih.com

For media inquiries please contact:

Michael Sharp
561-627-9455

For Investment Opportunities:

MFS Capital Advisors
917-562-9610

SOURCE: MMJ International Holdings

Read the full story at https://www.prweb.com/releases/dea_approves_mmj_international_holdings_thc_shipment_for_multiple_sclerosis_huntington_s_disease_drug_development/prweb16742984.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related medicine news :

1. FDA Approves Clinical Trial of a New approach to treat millions suffering from Enlarged Prostates
2. Capital Corp Merchant Banking Approves Funding for $30M Private Wellness Club in France
3. FDA Approves Study of New Aneurysm Device Developed by Sanford Health
4. World Patent Marketing Review Committee Approves Shave & Go Razors, The Best Razors for Every Skin Type
5. World Patent Marketing Review Committee Approves The MagneRing, A New Cycling Invention That Will Encourage More People To Bike To Work
6. World Patent Marketing Review Committee Approves Instant Captures, A New App Invention That Encourages Everyone To Capture The Moments
7. State Stem Cell Agency Approves Research Funding for UC Davis Scientists
8. World Patent Marketing Review Committee Approves The Instant Freeze Pack, A Household Invention That Will Beat The Summer Heat!
9. State of Illinois Approves OSF HealthCare's Request for Freestanding Emergency Center in Streator
10. World Patent Marketing Success Group Approves Global GPS Marketing, a New App Invention for Location Based Marketing
11. World Patent Marketing Review Committee Approves the Multi Jar, a New Multilayer Plastic Jar for Home or Commercial Use
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2019)... ... December 05, 2019 , ... ... young patients met the hospital's newest staff member who will to help them ... support and affection during medical procedures.  , Rocket, presented by NutriSource® is a ...
(Date:12/4/2019)... ... December 04, 2019 , ... ... Mesocarp Extract®, provides protection from disruptions to cells and tissue and inflammation that ... of Jet Lag, is available in a dietary supplement product called Prepair™ ...
(Date:12/4/2019)... ... December 04, 2019 , ... ... Insights Awards™, the only national awards dedicated to recognizing excellence in the areas ... awards were presented in nine different categories during the GlobeSt Healthcare Conference today ...
(Date:12/4/2019)... HILL, N.C. (PRWEB) , ... December 04, 2019 , ... ... their families easily find their way around the campuses of UNC Medical Center in ... inside the two hospitals, parking garages, clinics and more. , The free interactive app, ...
(Date:12/2/2019)... ... December 02, 2019 , ... More than $400 million dollars ... December 31. While many people spend their tax-free funds throughout the year, many more ... Year’s Eve. In an effort to help account holders use -- not lose -- ...
Breaking Medicine News(10 mins):
(Date:11/24/2019)... , ... November 24, 2019 , ... Jessica Du Bois, ... of 150 Benefits Advisors in the country to be accepted into the Health ... Virginia region with the Health Rosetta certification. Jessica’s acceptance into the program will provide ...
(Date:11/23/2019)... ... November 22, 2019 , ... Adolfson & Peterson Construction’s ... honoree at the Finance and Commerce Top Women in Finance awards on Thursday, ... and for their impressive impact on their companies and communities. Circle of Excellence ...
(Date:11/23/2019)... ... November 23, 2019 , ... Is age really ... celebrated -- has also broadly served as a marker of health, disease and ... make those assessments? , Researchers at the Institute for Systems Biology (ISB) harnessed ...
Breaking Medicine Technology: